Digg It - Business

The latest buzz is about having a lot of content on a Web site to please search engine robots, so that they wil

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

l give the site a good position on the search results. However, web designers are worried about being compromi

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ed when it comes to creating a great looking page design for web pages that does not leave much room for conten

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

, because some of them called a site that only displays content without some bell and whistle a bit boring.

It

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

might have some truth in it, because imaginative design could be intriguing and might even fight boredom. The

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

uestion is, as long a site has enough content somewhere else on the Web site that has a visible link to it, why

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

would search engines not be happy with it? In other words, why does content has to be in the first landing pag

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

when accessing it by anyone looking for content is possible as long as there is a link to it?

For the most pa

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

t, it makes sense, as having enough amount of informative content makes sense too. But the search engines migh

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

want visitors to be engulfed with a lot of informative content when they land on a page and if they were not p

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

anning to peruse through any content at all, its glaring at them might captivate them to do so.

The end result

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

is visitors do not hop from one site to the other, without getting information about a thing or two, but what

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ill happen if they are made to look for it. They might leave without doing so. If that is the outlook, conten

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

might have been shoved down their throat, but the fact that they have the option will make them opt-ins or opt

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

outs by choice.

Again, it is Google that made content a requirement more than the other search engines, and if

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

they have to be commended for it or not is up for grabs. At least surfing the Internet would have not been dif

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

erent than going through a catalogue, but still there is no gauging made on what users think about content. Do

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

they read them or they are just there to be irking? Seen from Web site’s point of view they are not only offer

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ng value for the visitors, but they want them to come again searching for more information. Yet, the Internet

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

is cluttered with information that is fighting for eyeballs, and along the way some Web sites might do business

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/28469/diggit-The-New-Buzz.html">The New Buzz</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/28469/diggit-The-New-Buzz.html]The New Buzz[/url]

Those who see ethical behavior as an inconvenience aren't just selling out their principles, they are also risking the success of their online business.

This seems to be an obvious principle. Yet, many troubled businesses are the result of petty quarrels and disagreements amongst partners and major shareholders. There are also many family-run companies where the family members soured their relationships ruining the business.

Tags

Links

Digg It - The New Buzz

Related Articles: